Research using the db/db mouse model, which simulates obesity, has shown increased levels of GLP1 can reduce histological signs of tubulointerstitial damage and decrease the renal expression of proinflammatory markers such as TNFα and Ccl5. Here, GLP1R is linked to obesity disorder.